Macrophages Are Critical Inducers of Bleomycin-Induced Fibrosis in a Systemic Scleroderma Model
The American Journal of Pathology · 2026
DOI: 10.1016/j.ajpath.2025.09.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Pathology, 2026. Verfasst von Blandine Baffert und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Franche-Comté, Etablissement Français du Sang (EFS), INSERM, Unité Mixte de Recherche (UMR) Regulation of Immunity for Therapeutic Inno…. Hauptthemen laut MEDLINE: Bleomycin, Scleroderma, Systemic, Macrophages. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Agence Nationale de la Recherche, Association des Sclérodermiques de France.
Abstract (Originalsprache)
Macrophages are critical regulators of inflammation with an essential role in maintaining and re-establishing homeostasis after inflammatory insults. However, excessive macrophage activation could promote fibrosis, highlighting their potential as a therapeutic target in chronic inflammatory diseases. Two preclinical models of systemic sclerosis, bleomycin-induced systemic scleroderma and sclerodermatous graft-versus-host disease, were used to analyze the role of macrophages in the establishment of fibrosis. In both models, macrophage numbers increase in the skin and lungs, in association with elevated collagen content and correlating with fibrosis development. These macrophages had a Ly6clowCD206+MerTk+ phenotype, suggesting a profibrotic role during disease progression. Using macrophage depletion and differentiation blocking approaches, this work shows that reduced macrophage accumulation effectively prevented bleomycin-induced fibrosis development. Direct profibrotic activity of bleomycin-exposed macrophages was revealed by s.c. macrophage injections in naïve mice, which was sufficient to induce systemic fibrosis. Finally, bleomycin-treated primary mouse and human macrophages display reduced clearance of apoptotic cells and secrete factors that promote fibroblast activation and collagen production. Metabolic and mitochondrial dysfunction, changes in receptor shedding, and cytoskeletal reorganization in bleomycin-treated macrophages further contribute to their impaired efferocytosis and enhanced profibrotic activity. Collectively, this work identifies macrophages as critical promoters of tissue fibrosis and suggests that inhibition of macrophage activation represents a new potent therapeutic avenue in efforts to reverse fibrosis associated with chronic inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Franche-Comté, Etablissement Français du Sang (EFS), INSERM, Unité Mixte de Recherche (UMR) Regulation of Immunity for Therapeutic Innovation in Graft, Host, Tumoral and Inflammatory Associated Diseases (R…
- Department of Medicine, Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia, Charlottesville, Virginia.
- Department of Medicine, Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia, Charlottesville, Virginia. Electronic address: sa2h@virginia.edu.
Förderung
- NIAID NIH HHS
- Agence Nationale de la Recherche
- Association des Sclérodermiques de France
- Conseil régional de Bourgogne-Franche-Comté
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Baffert, B., Schneider, K., Wetzel, A., Dal Zuffo, L., Chagué, C., Mitifiot, E., Bonnefoy, F., Kuzniewska, A., Saas, P., Bamoulid, J., Rolin, G., Perruche, S., & Arandjelovic, S. (2026). Macrophages Are Critical Inducers of Bleomycin-Induced Fibrosis in a Systemic Scleroderma Model. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2025.09.009
Vancouver
Baffert B, Schneider K, Wetzel A, Dal Zuffo L, Chagué C, Mitifiot E, et al. Macrophages Are Critical Inducers of Bleomycin-Induced Fibrosis in a Systemic Scleroderma Model. The American Journal of Pathology. 2026. doi:10.1016/j.ajpath.2025.09.009
BibTeX
@article{Baffert2026,
author = {Baffert, Blandine and Schneider, Kevin and Wetzel, Audrey and Dal Zuffo, Ludivine and Chagué, Cécile and Mitifiot, Eléa and Bonnefoy, Francis and Kuzniewska, Alicja and Saas, Philippe and Bamoulid, Jamal and Rolin, Gwenael and Perruche, Sylvain and Arandjelovic, Sanja},
title = {Macrophages Are Critical Inducers of Bleomycin-Induced Fibrosis in a Systemic Scleroderma Model},
journal = {The American Journal of Pathology},
year = {2026},
doi = {10.1016/j.ajpath.2025.09.009}
}
EUVIMED